403 related items for PubMed ID: 19441604
1. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
Edin HM, Andersen LB, Schoaf L, Scott-Wilson CA, Ho SY, Ortega HG.
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604
[Abstract] [Full Text] [Related]
2. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
3. Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
Lumry WR, Conway MM, LaForce CF, Pearlman DS, Scott CA, Herje NE, Wu WW, Crim C.
Ann Allergy Asthma Immunol; 2006 Jan; 96(1):51-9. PubMed ID: 16440533
[Abstract] [Full Text] [Related]
4. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P.
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):263-9. PubMed ID: 14533658
[Abstract] [Full Text] [Related]
5. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M.
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[Abstract] [Full Text] [Related]
6. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
You-Ning L, Humphries M, Du X, Wang L, Jiang J.
Int J Clin Pract; 2005 Jul; 59(7):754-9. PubMed ID: 15963199
[Abstract] [Full Text] [Related]
7. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[Abstract] [Full Text] [Related]
8. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
9. Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma.
Pinnas JL, Noonan MJ, Weinstein SF, Chervinsky P, Scott CA, Herje NE, Wu W, Crim C.
J Asthma; 2005 Dec; 42(10):865-71. PubMed ID: 16393726
[Abstract] [Full Text] [Related]
10. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[Abstract] [Full Text] [Related]
11. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A, Jarvis B.
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[Abstract] [Full Text] [Related]
12.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
13. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.
Can Respir J; 1999 Nov; 6(1):45-51. PubMed ID: 10202220
[Abstract] [Full Text] [Related]
14.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma.
Pearlman DS, Peden D, Condemi JJ, Weinstein S, White M, Baitinger L, Scott C, Ho SY, House K, Dorinsky P.
J Asthma; 2004 Nov; 41(8):797-806. PubMed ID: 15641629
[Abstract] [Full Text] [Related]
16. Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction.
Sheth K, Wasserman RL, Lincourt WR, Locantore NW, Carranza-Rosenzweig J, Crim C.
Int J Clin Pract; 2006 Oct; 60(10):1218-24. PubMed ID: 16981966
[Abstract] [Full Text] [Related]
17. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
Kosoglou T, Hubbell J, Cutler DL, Johnson-Levonas AO, Xu D, Kantesaria BS, Kim K, Miller SD.
Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
[Abstract] [Full Text] [Related]
18.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
19. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M.
J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
[Abstract] [Full Text] [Related]
20.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
Page: [Next] [New Search]
